Search results
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 3 days agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...
Spartan Planning & Wealth Management Sells 194 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoSpartan Planning & Wealth Management cut its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.3% in the fourth quarter, according to the company in its most recent disclosure ...
Encouraging cooperation in inflammatory arthritis
Medical Xpress· 7 days agoNow, new survey data presented at the 2024 EULAR congress showcase the benefits of cooperation between different stakeholders. Inflammatory arthritis describes a group of diseases caused by ...
Amgen Inc. (NASDAQ:AMGN) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 4 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 9,050,000 shares, a decrease of ...
Bath Savings Trust Co Acquires 196 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 20 hours agoBath Savings Trust Co increased its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by S. R. Schill & Associates
ETF DAILY NEWS· 23 hours agoS. R. Schill & Associates lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 11.8% in the first quarter, Holdings Channel reports. The institutional investor owned ...
Walden Wealth Partners LLC Purchases New Shares in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoWalden Wealth Partners LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 2 days agoSkyrizi’s approval for the UC indication was based on data from two phase III studies, a 12-week induction study, INSPIRE1 and a 52-week maintenance study, COMMAND2. Skyrizi is already approved ...
Burkett Financial Services LLC Sells 122 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoBurkett Financial Services LLC decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.1% in the first quarter, according to the company in its most recent 13F filing ...
Short Interest in UCB SA (OTCMKTS:UCBJY) Rises By 152.5%
ETF DAILY NEWS· 7 days agoUCB SA (OTCMKTS:UCBJY – Get Free Report) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 15,400 shares, a growth of 152.5% from ...